CLSDQ

Clearside Biomedical, Inc. OTC Listed Jun 2, 2016

Healthcare ·Biotechnology ·US · clearsidebio.com

$0.32

Mkt Cap $1.7M

52w Low $0.11 1.5% of range 52w High $14.09

50d MA $0.44 200d MA $2.49

P/E (TTM) -0.0x

EV/EBITDA -4.2x

P/B —

Debt/Equity -1.4x

ROE 60.5%

P/FCF -2.7x

RSI (14) —

ATR (14) —

Beta 2.02

50d MA $0.44

200d MA $2.49

Avg Volume 24.4K

About

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Nov 14, 2025	AMC	-0.67	-1.14	-70.1%	3.82	-5.0%	-12.6%	-19.6%	-25.1%	-31.7%	-28.8%	—
Aug 8, 2025	AMC	-1.80	-0.90	+50.0%	6.12	-3.8%	-1.1%	+6.4%	+9.2%	+10.1%	+3.6%	—
May 14, 2025	AMC	-0.12	-0.11	+8.3%	12.81	+1.7%	+1.3%	+3.0%	+4.0%	+3.0%	-1.2%	—
Mar 27, 2025	AMC	-0.13	-0.10	+23.1%	15.45	-4.9%	-7.8%	-10.9%	-11.8%	-9.7%	-12.6%	—
Nov 12, 2024	AMC	-0.14	-0.10	+28.6%	16.65	-2.7%	-2.7%	-5.4%	-10.8%	-8.1%	-7.2%	—
Aug 12, 2024	AMC	-0.14	-0.10	+28.6%	16.05	-1.9%	-0.4%	-4.7%	-1.4%	-5.6%	-4.7%	—
May 9, 2024	AMC	-0.14	-0.17	-21.4%	20.25	-3.7%	-7.4%	-8.9%	-5.2%	-2.2%	-3.0%	—
Mar 12, 2024	AMC	-0.10	-0.08	+20.0%	24.60	+6.1%	-0.6%	+5.5%	+4.3%	-4.9%	-0.6%	—
Nov 13, 2023	AMC	-0.16	-0.15	+6.2%	14.55	+7.2%	-2.2%	-1.0%	-4.9%	-1.7%	+0.2%	—
Aug 14, 2023	AMC	-0.14	-0.15	-7.1%	15.90	+0.0%	-6.6%	-12.1%	-13.2%	-11.3%	-10.4%	—
May 11, 2023	AMC	-0.14	-0.15	-7.1%	16.20	+0.0%	-2.8%	-0.9%	-3.7%	-3.7%	-6.5%	—
Mar 9, 2023	AMC	-0.13	-0.16	-23.1%	17.85	+3.4%	-9.2%	-11.8%	-13.4%	-17.6%	-19.4%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Nov 18	Needham	Maintains	Hold → Hold	—	$3.34	$3.31	-0.9%	-8.1%	-14.4%	-21.9%	-18.6%	-73.1%
Aug 14	Needham	Maintains	Buy → Buy	—	$15.75	$15.30	-2.9%	+1.0%	-5.7%	-11.3%	-12.4%	-10.5%
Aug 14	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$15.75	$15.30	-2.9%	+1.0%	-5.7%	-11.3%	-12.4%	-10.5%
Aug 14	HC Wainwright & Co.	Maintains	Buy → Buy	—	$15.75	$15.30	-2.9%	+1.0%	-5.7%	-11.3%	-12.4%	-10.5%
Jul 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$19.05	$19.20	+0.8%	-2.4%	-2.4%	-2.4%	-3.9%	-4.7%
Jul 11	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$15.90	$15.90	+0.0%	+3.8%	+5.7%	+11.3%	+13.2%	+19.8%
Jul 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	—	—	—	—	—	—	—	—
May 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$15.90	$15.90	+0.0%	+1.9%	+5.7%	+8.5%	+8.5%	+19.8%
May 11	HC Wainwright & Co.	Maintains	Buy → Buy	—	$17.40	$17.40	+0.0%	-6.9%	-9.5%	-7.8%	-10.3%	-10.3%
Apr 28	JMP Securities	Maintains	Market Outperform → Outperform	—	$15.30	$15.60	+2.0%	-1.0%	-2.0%	-3.9%	-2.4%	-4.8%
Apr 20	Needham	Maintains	Buy → Buy	—	$17.25	$16.80	-2.6%	-2.6%	-7.8%	-4.3%	-7.0%	-8.3%
Apr 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$16.80	$16.95	+0.9%	+2.7%	+0.0%	-5.4%	-1.8%	-4.5%
Mar 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$17.85	$18.45	+3.4%	-9.2%	-11.8%	-13.4%	-17.6%	-19.4%
Mar 9	Needham	Maintains	Buy → Buy	—	$18.45	$18.45	+0.0%	-3.3%	-12.2%	-14.6%	-16.3%	-20.3%
Mar 9	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$18.45	$18.45	+0.0%	-3.3%	-12.2%	-14.6%	-16.3%	-20.3%
Feb 13	JMP Securities	Maintains	Market Outperform → Outperform	—	$19.80	$19.65	-0.8%	+1.5%	+0.0%	+1.5%	+3.0%	+4.5%
Feb 3	Needham	Maintains	Buy → Buy	—	$22.35	$22.95	+2.7%	+1.3%	-1.3%	-0.7%	-4.7%	-8.7%
Nov 9	Needham	Upgrade	Hold → Buy	—	$21.00	$19.50	-7.1%	-8.6%	-5.7%	-5.0%	-2.1%	+0.7%
Nov 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$21.00	$19.50	-7.1%	-8.6%	-5.7%	-5.0%	-2.1%	+0.7%
Nov 9	Stifel	Upgrade	Hold → Buy	—	$21.00	$19.50	-7.1%	-8.6%	-5.7%	-5.0%	-2.1%	+0.7%
Aug 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$24.60	$27.00	+9.8%	-1.8%	-1.2%	-5.5%	-3.0%	-6.1%
Mar 10	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$22.35	$21.60	-3.4%	-9.4%	+29.2%	+39.6%	+67.1%	+67.1%
Jul 29	HC Wainwright & Co.	Maintains	Buy → Buy	—	$76.80	$81.45	+6.1%	+1.8%	-3.9%	+1.2%	+0.2%	-0.4%
Jun 16	Wedbush	Maintains	Outperform → Outperform	—	$62.40	$56.70	-9.1%	-1.9%	+11.5%	+16.3%	+8.4%	+9.1%
Jun 14	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$45.15	$45.60	+1.0%	+0.3%	+38.2%	+35.5%	+54.2%	+60.8%
May 13	Roth Capital	Maintains	Buy → Buy	—	$29.40	$32.25	+9.7%	+5.6%	+8.7%	+1.0%	+3.1%	-4.6%
Jan 26	Wedbush	Maintains	Outperform → Outperform	—	—	—	—	—	—	—	—	—
Jul 16	Laidlaw & Co.	Maintains	Buy → Buy	—	$154.20	$158.70	+2.9%	+3.4%	+0.9%	+0.9%	-2.8%	-2.7%
Jun 28	Janney Capital	Maintains	Buy → Buy	—	$153.15	$162.15	+5.9%	+5.2%	+4.7%	+5.5%	+8.2%	+5.8%
Mar 5	JP Morgan	Maintains	Overweight → Overweight	—	$117.30	$165.43	+41.0%	+32.1%	+65.6%	+82.6%	+66.2%	+66.2%
May 25	JMP Securities	Maintains	Market Outperform → Outperform	—	$113.10	$119.10	+5.3%	-0.5%	-3.8%	-6.5%	-8.8%	-5.0%
Feb 24	JP Morgan	Maintains	Overweight → Overweight	—	$103.50	$115.50	+11.6%	+16.8%	+25.2%	+13.8%	+22.5%	+23.6%
Jun 27	Cowen & Co.	Maintains	Outperform → Outperform	—	$102.00	$102.15	+0.1%	+2.9%	+1.6%	+1.9%	+3.1%	-0.3%
Jun 27	Stifel Nicolaus	Maintains	Buy → Buy	—	$102.00	$102.15	+0.1%	+2.9%	+1.6%	+1.9%	+3.1%	-0.3%
Jun 27	Wedbush	Maintains	Outperform → Outperform	—	$102.00	$102.15	+0.1%	+2.9%	+1.6%	+1.9%	+3.1%	-0.3%

Data updated apr 27, 2026 11:24pm · Source: massive.com